Consolidated statement of changes in equity

January 1 – December 31

Attributable to shareholders of medmix Ltd

millions of CHF

Notes

Share capital

Retained earnings

Treasury shares

Cash flow hedge reserve

Currency translation adjustment

Total

Non-controlling interests

Total equity

Equity as of January 1, 2022

0.4

552.8

–6.5

–0.6

–12.2

533.9

–

533.9

Comprehensive income for the period:

Net income

11.6

–

11.6

– Cash flow hedges, net of tax

–

1.2

–

1.2

–

1.2

– Remeasurements of defined benefit plans, net of tax

–4.7

–

–4.7

–

–4.7

– Currency translation differences

–

–11.9

–

–11.9

Other comprehensive income

–4.7

–

1.2

–11.9

–15.4

–

–15.4

Total comprehensive income for the period

6.8

–

1.2

–11.9

–3.9

–

–3.9

Contribution to the Sulzer group

–0.4

–

–0.4

–

–0.4

Transactions with owners of the company:

Allocation of treasury shares to share plan participants

–0.1

0.1

–

Purchase of treasury shares

–

–6.1

–

–6.1

–

–6.1

Share-based payments

1.8

–

1.8

–

1.8

Dividends

–20.5

–

–20.5

–

–20.5

Equity as of December 31, 2022

0.4

540.3

–12.5

0.7

–24.1

504.8

–

504.8

Equity as of January 1, 2023

0.4

540.3

–12.5

0.7

–24.1

504.8

–

504.8

Comprehensive income for the period:

Net income

0.3

0.4

0.7

– Cash flow hedges, net of tax

–

–1.6

–

–1.6

–

–1.6

– Remeasurements of defined benefit plans, net of tax

–

19.5

–

19.5

–

19.5

– Currency translation differences

–

–24.6

–0.4

–25.0

Other comprehensive income

–

19.5

–

–1.6

–24.6

–6.7

–0.4

–7.1

Total comprehensive income for the period

–

19.8

–

–1.6

–24.6

–6.4

–0.0

–6.4

Sale of investments in subsidiaries

–

–2.0

–

–2.0

–

–2.0

Put option liability

–

–9.8

–

–9.8

–

–9.8

Contribution to the Sulzer group

–

–0.3

–

–0.3

–

–0.3

Transactions with owners of the company:

Acquisition of subsidiary with non-controlling interests

–

9.0

Allocation of treasury shares to share plan participants

–

–0.4

0.4

–

Purchase of treasury shares

–

–3.1

–

–3.1

–

–3.1

Share-based payments

–

2.5

–

2.5

–

2.5

Dividends

–

–20.5

–

–20.5

–

–20.5

Equity as of December 31, 2023

0.4

529.8

–15.2

–0.9

–48.7

465.4

9.0

474.3